NYSE - Delayed Quote USD
ResMed Inc. (RMD)
240.10 -0.23 (-0.10%)
At close: August 31 at 4:00:02 PM EDT
238.82 -1.28 (-0.53%)
Pre-Market: 6:22:21 AM EDT
Trade ResMed on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for RMD
What's happening with RMD?
Powered by Yahoo ScoutResMed faces challenges with a soft fiscal 2027 outlook, primarily due to suspended Astral ventilator sales and higher costs, despite reporting a 9% revenue increase in Q4 fiscal 2026. Analysts have mixed views on the stock's valuation, with some indicating it may be 31% undervalued based on long-term cash flow projections.
Powered by Yahoo Scout
- Previous Close
240.33 - Open
237.97 - Bid --
- Ask --
- Day's Range
236.16 - 241.71 - 52 Week Range
180.27 - 284.87 - Volume
-- - Avg. Volume
-- - Market Cap (intraday)
34.635B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
Statistics
View MoreValuation Measures
As of 8/27/2026
Market Cap
34.01B
Enterprise Value
33.37B
Trailing P/E
22.60
Forward P/E
19.65
PEG Ratio (5yr expected)
1.37
Price/Sales (ttm)
6.09
Price/Book (mrq)
5.16
Enterprise Value/Revenue
5.90
Enterprise Value/EBITDA
15.50
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Mkt Cap undefined -
Industry -
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreRaising target price to $260.00
RESMED INC has an Investment Rating of BUY; a target price of $260.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.
RatingPrice TargetLowering target price to $242.00
RESMED INC has an Investment Rating of BUY; a target price of $242.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $247.00
RESMED INC has an Investment Rating of BUY; a target price of $247.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetSMID August 2026 Pick List
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.